CN112426448A - 一种养生茶的配制方法 - Google Patents
一种养生茶的配制方法 Download PDFInfo
- Publication number
- CN112426448A CN112426448A CN202011643393.XA CN202011643393A CN112426448A CN 112426448 A CN112426448 A CN 112426448A CN 202011643393 A CN202011643393 A CN 202011643393A CN 112426448 A CN112426448 A CN 112426448A
- Authority
- CN
- China
- Prior art keywords
- parts
- health tea
- preparation
- blood
- cyclocarya paliurus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Otolaryngology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
Abstract
本发明涉及中药配方技术领域,尤其涉及一种养生茶的配制方法。该一种养生荼的配制方法包括如下重量份:成分罗布麻3‑5份;绞股蓝3‑5份;青钱柳叶3‑5份;丹参3‑5份;葛根3‑5份。本发明提供的一种养生茶的配制方法,具有如下功能:平肝潜阳,延缓衰老,降压降脂降糖,活血化瘀,利水渗湿,宁心安神。能够治疗头晕耳鸣、易烦躁、心肌缺血、胸闷胸痛、多吃多喝、降糖、降脂、降血压、心慌,抑郁易怒,恶心呕吐,嗜睡发困,贪吃体胖,四肢体麻木,过度吃药,吃酒应酬等病症。
Description
技术领域
本发明涉及中药配方技术领域,尤其涉及一种养生茶的配制方法。
背景技术
目前,药茶是祖国医学宝库中一个重要组成部分,其应用历史非常悠久,历代医书均有记载。相传茶的发现与使用源于神农氏,我国最早的药物学专著神农本草经中有“神农尝百草,一日遇七十二毒,得茶而解”的记载。
随着人们生活节奏的加快,工作压力的增加,抽烟喝酒、偏食、饮食无节及休眠不足导致器官生理功能衰退等自我老化现象,特别是肝脏,肝脏为人体消化***中最大、最重要的消化腺体,具有重要的消化功能,是人体的主要代谢器官和防御器官,它对人体外来的和代谢产生的许多有害因素实施其强大的防御解毒功能。一般情况下,肝脏对化学毒物有很强的生物转化、解毒功能。但现代社会,由于环境污染(空气、水、食物),滥用药物,食用农残超标食品,不良饮酒习惯等因素都加重了人体内肝脏的消化、代谢、解毒能力,使肝脏本身的防御解毒功能降低,进而引发不同程度化学性肝损伤。一旦肝脏受损将会不同程度的殃及人体的其他脏器。单纯地用药物治疗花费甚多。为此,以预防和食疗为主导,调节及促进肝脏健康,增强免疫功能,提高生存能力,逐渐成为医学界、中药界领域研究的重点。
发明内容
针对现有技术的上述缺陷,本发明提供的一种养生茶的配制方法,解决了上述技术问题,提供一种以解决上述背景技术中提出的问题的一种养生茶的配制方法。
为了达到上述目的,本发明提供如下技术方案:
一种养生茶的配制方法,包括如下重量份:成分罗布麻3一5份;绞股蓝3一5份;青钱柳叶3一5份;丹参3一5份;葛根3一5份。
一种养生茶的配制方法,包括如下重量份:成分罗布麻4份;绞股蓝4份;青钱柳叶4份;丹参4份;葛根4份。
一种养生茶的配制方法,包括如下重量份:成分罗布麻3份;绞股蓝3份;青钱柳叶3份;丹参5份;葛根3份。
一种养生茶的配制方法,包括如下重量份:成分罗布麻5份;绞股蓝5份;青钱柳叶5份;丹参3份;葛根5份。
一种养生茶的配制方法,包括如下制备方法:将成分罗布麻、绞股蓝、青钱柳叶、丹参和葛根混合后泡水。
本发明的有益效果是:本发明提供的一种养生茶的配制方法,具有如下功能:平肝潜阳,延缓衰老,降压降脂降糖,活血化瘀,利水渗湿,宁心安神。能够治疗头晕耳鸣、易烦躁、心肌缺血、胸闷胸痛、多吃多喝、降糖、降脂、降血压、心慌,抑郁易怒,恶心呕吐,嗜睡发困,贪吃体胖,四肢体麻木,过度吃药,吃酒应酬等病症。
为了能更进一步了解本发明的特征以及技术内容,请参阅以下有关本发明的详细说明。
具体实施方式
为更进一步阐述本发明所采取的技术手段及其效果,以下结合本发明的优选实施例进行详细描述。
一种养生茶的配制方法,包括如下重量份:成分罗布麻3一5份;绞股蓝3一5份;青钱柳叶3一5份;丹参3一5份;葛根3一5份。
实施例1:
一种养生茶的配制方法,包括如下重量份:成分罗布麻4份;绞股蓝4份;青钱柳叶4份;丹参4份;葛根4份。
实施例2:
一种养生茶的配制方法,包括如下重量份:成分罗布麻3份;绞股蓝3份;青钱柳叶3份;丹参5份;葛根3份。
实施例3:
一种养生茶的配制方法,包括如下重量份:成分罗布麻5份;绞股蓝5份;青钱柳叶5份;丹参3份;葛根5份。
一种养生茶的配制方法,包括如下制备方法:将成分罗布麻、绞股蓝、青钱柳叶、丹参和葛根混合后泡水。
养生茶保留茶的特点和饮茶习惯,增加养生调理功能,更好的调理身体,益肝气,安心神,通经络,理脾胃,提高身体抵抗力,降低环境污染危害,降低慢性病风险,防三高,减少癌症风险。
服用方法:直接开水浸泡服用。
养生茶效果测试:
临床资料本组病例50例,均符合高脂血症诊断标准(《中华心血管杂志》编委会血脂异常防治对策专题组制定的血脂异常诊断标准)〖中华心血管病杂志编委会。血脂异常防治对策专题组。血脂异常防治建议[J]。中华心血管病杂志,1997,25(3):169.】,其中男25例,女25例;年龄30-50岁,平均40岁。
使用本实施例1中制得的养生茶来进行治疗,其中一天2次,每次6克,治疗2个月为一个疗程。
参照《中药新药临床研究指导原则》(***.中药新药临床研究指导原则(试行)[S].北京.中国医药科技出版社,2002:85~89.)制订疗效标准。分别在治疗前后均空腹12h后于清晨抽取静脉血,测定TC、TG、LDL-C、HDL-C、心肝、肾功能及血、尿、粪常规等各项指标。
经过有一个疗程的观察,发现有45位患者治疗效果显效,5位患者治疗效果有效,总有效率率为100%,并且在整个治疗期间未观察到明显的不良反应。
在治疗一个疗程后每周对患者进行随访,持续半年,并未发现复发的迹象。
可以看出本发明在临床上的应用有显著的疗效。
注意事项:孕妇、经期、哺乳期的人及脾虚腹泻者不能食用。
典型案例:
患者资料:女性,36周岁;
症状:无精打采,浑身乏力,抵抗力弱;
疗养:按实施例1提供的养生茶,每日两次,每次5g连续饮用一个月;
疗效:抵抗力增加,乏力现象消失,神采奕奕。
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应所述以权利要求的保护范围为准。
Claims (5)
1.一种养生茶的配制方法,其特征在于,包括如下重量份:成分罗布麻3一5份;绞股蓝3一5份;青钱柳叶3一5份;丹参3一5份;葛根3一5份。
2.根据权利要求1所述的一种养生茶的配制方法,其特征在于,包括如下重量份:成分罗布麻4份;绞股蓝4份;青钱柳叶4份;丹参4份;葛根4份。
3.根据权利要求1所述的一种养生茶的配制方法,其特征在于,包括如下重量份:成分罗布麻3份;绞股蓝3份;青钱柳叶3份;丹参5份;葛根3份。
4.根据权利要求1所述的一种养生茶的配制方法,其特征在于,包括如下重量份:成分罗布麻5份;绞股蓝5份;青钱柳叶5份;丹参3份;葛根5份。
5.根据权利要求1所述的一种养生茶的配制方法,其特征在于,包括如下制备方法:将成分罗布麻、绞股蓝、青钱柳叶、丹参和葛根混合后泡水。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011643393.XA CN112426448A (zh) | 2020-12-31 | 2020-12-31 | 一种养生茶的配制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011643393.XA CN112426448A (zh) | 2020-12-31 | 2020-12-31 | 一种养生茶的配制方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112426448A true CN112426448A (zh) | 2021-03-02 |
Family
ID=74697103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011643393.XA Pending CN112426448A (zh) | 2020-12-31 | 2020-12-31 | 一种养生茶的配制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112426448A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113476578A (zh) * | 2021-07-20 | 2021-10-08 | 郑相松 | 一种防治三高症的黑松茶及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104171137A (zh) * | 2014-08-14 | 2014-12-03 | 刘本德 | 降压降脂茶 |
CN105981840A (zh) * | 2015-02-26 | 2016-10-05 | 北京福寿星绿色食品科技有限责任公司 | 一种降血脂、降血糖、降血压的中药茶及制作方法 |
CN111568945A (zh) * | 2020-04-02 | 2020-08-25 | 湖南清雅健康服务有限公司 | 一种复方青钱柳制剂 |
-
2020
- 2020-12-31 CN CN202011643393.XA patent/CN112426448A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104171137A (zh) * | 2014-08-14 | 2014-12-03 | 刘本德 | 降压降脂茶 |
CN105981840A (zh) * | 2015-02-26 | 2016-10-05 | 北京福寿星绿色食品科技有限责任公司 | 一种降血脂、降血糖、降血压的中药茶及制作方法 |
CN111568945A (zh) * | 2020-04-02 | 2020-08-25 | 湖南清雅健康服务有限公司 | 一种复方青钱柳制剂 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113476578A (zh) * | 2021-07-20 | 2021-10-08 | 郑相松 | 一种防治三高症的黑松茶及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103627604B (zh) | 一种益肾保健酒及其制备方法 | |
CN102048933A (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN101530597B (zh) | 一种治疗***纤维腺瘤和乳腺增生病的药物 | |
CN101234164B (zh) | 改善皮肤油水平衡与痤疮症状的药物组合物及其制备方法 | |
CN101732562B (zh) | 补肾强心,化瘀通络的中药 | |
CN103041256A (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN102813870A (zh) | 一种治疗酒精中毒痛风的中药复方制剂及制备方法与应用 | |
CN112426448A (zh) | 一种养生茶的配制方法 | |
CN105999049A (zh) | 一种治疗慢性肾衰竭及其引发症的中药组合物 | |
CN105663900B (zh) | 一种用于改善肝硬化营养状态的药膳 | |
CN102091228B (zh) | 一种治疗失眠的药物及其制备方法 | |
CN108434287A (zh) | 一种中药组合物及其制备方法和应用 | |
CN103223137B (zh) | 一种降血糖的中药制剂 | |
CN102552677B (zh) | 黄地安消胶囊及其制备方法 | |
CN105168946A (zh) | 一种治疗糖尿病的中药组合物及其用途 | |
CN105031302A (zh) | 一种辅助治疗艾滋病免疫功能重建不全的中药组合物 | |
CN1327874C (zh) | 治疗慢性***炎的中药制剂及其制备方法 | |
CN104173745A (zh) | 一种滋补健身的蒙药 | |
CN104367753A (zh) | 一种治疗2型糖尿病的中药组合物 | |
CN114191514B (zh) | 一种用于预防和治疗痰湿型肥胖症的中药组合物 | |
CN108524740A (zh) | 一种治疗类风湿关节炎的中药方剂 | |
CN101693096A (zh) | 一种治疗肝癌的药物及其制备方法 | |
CN101653495B (zh) | 治疗失眠的中药药物 | |
CN105943860A (zh) | 一种用于治疗糖尿病的药物制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210302 |